Ophthalmic Consultants of Connecticut\u00a0 (OCC) is currently seeking participants who have been treated, without success, for glaucoma, for one of three separate clinical trials currently underway or scheduled to begin shortly. The individual trials will address issues including lowering eye pressure due to glaucoma with the possibility of reducing dependence on glaucoma medication; treatment of glaucoma in conjunction with cataract surgery; an alternative to unsuccessful procedures including, but not limited to trabeculectomy, express minishunt, cyclocryotherapy. The studies will extend over a 12-month period, depending on the specific trial. To be considered, participants must be at least 18 and have been diagnosed with glaucoma. In addition, they must have undergone treatment or treatments for glaucoma that were not successful. Each trial has a set of criteria, including age range, previous or current ocular treatments and current vision health. If interested, potential patients should contact OCC as soon as possible. For a full list of criteria, potential patients should contact OCC Research Coordinator Denise Lavin at 203-366-8000.